Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).
Maggioni G, Todisco G, Sauta E, Lanino L, Ball S, Bewersdorf JP, Kewan T, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Xie Z, Brunner AM, Kuykendall AT, Bennett JM, Buckstein R, Bejar R, Carraway HE, DeZern AE, Griffiths EA, Halene S, Hasserjian RP, List AF, Loghavi S, Odenike O, Padron E, Patnaik MM, Roboz GJ, Stahl M, Sekeres MA, Steensma DP, Savona MR, Taylor J, Xu ML, Sallman DA, Nimer SD, Hourigan CS, Wei AH, Campagna A, Ubezio M, Riva E, Ventura D, Pinocchio N, Zampini M, Buizza A, Russo A, Pesce F, D'Amico S, Asti G, Delleani M, Travaglino E, Tentori CA, Ferrari I, Crespi A, Figini G, Di Matteo M, Brindisi M, Manes N, Milanesi C, Crisafulli L, Ficara F, Castellani G, Borate UM, Efficace F, Gore SD, Kim TK, Diez-Campelo M, van de Loosdrecht AA, Daver N, Rozman M, Orfao A, Wang SA, Foucar K, Iastrebner M, Scheinberg P, Miyazaki Y, Madanat YF, Al-Kali A, Mittelmann M, Cluzeau T, Ades L, Germing U, Garcia-Manero G, Kordasti S, Haferlach T, Zeidan AM, Komrokji RS, Della Porta MG; An international study on behalf of GenoMed4all, Synthema, and icMDS consortia.
Maggioni G, et al. Among authors: campagna a.
Hemasphere. 2026 Jun 22;10(6):e70406. doi: 10.1002/hem3.70406. eCollection 2026 Jun.
Hemasphere. 2026.
PMID: 42339339
Free PMC article.